insulin latin insula island peptide hormone produced beta cells pancreatic islets encoded humans insulin ins gene considered main anabolic hormone regulates metabolism carbohydrates fats protein promoting absorption glucose blood liver fat skeletal muscle tissues absorbed glucose converted either glycogen via glycogenesis fats triglycerides via lipogenesis case liver glucose production secretion liver strongly inhibited high concentrations insulin circulating insulin also affects synthesis proteins wide variety tissues therefore anabolic hormone promoting conversion small molecules blood large molecules inside cells low insulin levels blood opposite effect promoting widespread catabolism especially reserve body fat beta cells sensitive blood sugar levels secrete insulin blood response high level glucose inhibit secretion insulin glucose levels insulin production also regulated glucose high glucose promotes insulin production low glucose levels lead lower insulin enhances glucose uptake metabolism cells thereby reducing blood sugar level neighboring alpha cells taking cues beta secrete glucagon blood opposite manner increased secretion blood glucose low decreased secretion glucose concentrations high glucagon increases blood glucose level stimulating glycogenolysis gluconeogenesis secretion insulin glucagon blood response blood glucose concentration primary mechanism glucose decreased absent insulin activity results diabetes mellitus condition high blood sugar level hyperglycaemia two types disease diabetes mellitus type beta cells destroyed autoimmune reaction insulin longer synthesized secreted diabetes mellitus type destruction beta cells less pronounced type due autoimmune process instead accumulation amyloid pancreatic islets likely disrupts anatomy pathogenesis type diabetes well understood reduced population islet betacells reduced secretory function islet betacells survive peripheral tissue insulin resistance known type diabetes characterized increased glucagon secretion unaffected unresponsive concentration blood glucose insulin still secreted blood response blood result glucose accumulates blood human insulin protein composed amino acids molecular mass da heterodimer achain bchain linked together disulfide bonds insulins structure varies slightly species animals insulin nonhuman animal sources differs somewhat effectiveness carbohydrate metabolism effects human insulin variations porcine insulin especially close human version widely used treat type diabetics human insulin could produced large quantities recombinant dna insulin first peptide hormone frederick banting charles best working laboratory john macleod university toronto first isolate insulin dog pancreas frederick sanger sequenced amino acid structure made insulin first protein fully crystal structure insulin solid state determined dorothy hodgkin insulin also first protein chemically synthesised produced dna recombinant model list essential medicines important medications needed basic health insulin may originated billion years molecular origins insulin go least far back simplest unicellular apart animals insulinlike proteins also known exist fungi insulin produced beta cells pancreatic islets vertebrates brockmann body teleost cone snails conus geographus conus tulipa venomous sea snails hunt small fish use modified forms insulin venom cocktails insulin toxin closer structure fishes snails native insulin slows prey fishes lowering blood glucose insulin produced exclusively beta cells pancreatic islets mammals brockmann body fish human insulin produced ins gene located chromosome rodents two functional insulin genes one homolog mammalian genes retroposed copy includes promoter sequence missing intron transcription insulin gene increases response elevated blood primarily controlled transcription factors bind enhancer sequences base pairs genes transcription start major transcription factors influencing insulin secretion lowglucose state pancreatic duodenal homeobox protein located nuclear periphery result interaction results downregulation insulin increase blood glucose levels causes phosphorylation leads undergo nuclear translocation bind element within insulin upon translocation interacts coactivators hat affects histone modifications acetylation deacetylation well methylation also said suppress also known regulates insulin exocytosis pancreatic β cells directly inducing expression genes involved localized cytosol response high glucose becomes glycosylated ogt andor phosphorylated erk causes translocation nucleus nucleus heterodimerizes binds element insulin promoter recruits coactivator acetylates able interact transcription factors well activation insulin mafa degraded proteasomes upon low blood glucose levels increased levels glucose make unknown protein glycosylated protein works transcription factor mafa unknown manner mafa transported cell mafa translocated back nucleus binds element insulin transcription factors work synergistically complex arrangement increased blood glucose destroy binding capacities proteins therefore reduce amount insulin secreted causing diabetes decreased binding activities mediated glucose induced oxidative stress antioxidants said prevent decreased insulin secretion glucotoxic pancreatic β cells stress signalling molecules reactive oxygen species inhibits insulin gene interfering cofactors binding transcription factors transcription factors several regulatory sequences promoter region human insulin gene bind transcription factors general aboxes bind factors eboxes bind neurod cboxes bind mafa camp response elements creb also silencers inhibit transcription insulin synthesized inactive precursor molecule amino acidlong protein called preproinsulin preproinsulin translated directly rough endoplasmic reticulum rer signal peptide removed signal peptidase form proinsulin folds opposite ends protein called achain bchain fused together three disulfide folded proinsulin transits golgi apparatus packaged specialized secretory granule proinsulin cleaved proprotein convertase proprotein convertase removing middle part protein called finally carboxypeptidase e removes two pairs amino acids proteins ends resulting active insulin insulin b chains connected two disulfide resulting mature insulin packaged inside mature granules waiting metabolic signals leucine arginine glucose mannose vagal nerve stimulation exocytosed cell insulin related proteins shown produced inside brain reduced levels proteins linked alzheimers insulin release stimulated also receptor stimulation inhibited receptor stimulation addition cortisol glucagon growth hormone antagonize actions insulin times stress insulin also inhibits fatty acid release hormonesensitive lipase adipose contrary initial belief hormones would generally small chemical molecules first peptide hormone known structure insulin found quite single protein monomer human insulin composed amino acids molecular mass da molecular formula human insulin combination two peptide chains dimer named achain bchain linked together two disulfide bonds achain composed amino acids bchain consists residues linking interchain disulfide bonds formed cysteine residues positions additional intrachain disulfide bond within achain cysteine residues positions achain exhibits two αhelical regions antiparallel b chain central α helix covering residues flanked disulfide bond either sides two βsheets covering amino acid sequence insulin strongly conserved varies slightly species bovine insulin differs human three amino acid residues porcine insulin one even insulin species fish similar enough human clinically effective humans insulin invertebrates quite similar sequence human insulin similar physiological effects strong homology seen insulin sequence diverse species suggests conserved across much animal evolutionary history cpeptide proinsulin however differs much among species also hormone secondary insulin produced stored body hexamer unit six insulin molecules active form monomer hexamer da size six molecules linked together three dimeric units form symmetrical molecule important feature presence zinc atoms axis symmetry surrounded three water molecules three histidine residues position hexamer inactive form longterm stability serves way keep highly reactive insulin protected yet readily available hexamermonomer conversion one central aspects insulin formulations injection hexamer far stable monomer desirable practical reasons however monomer much fasterreacting drug diffusion rate inversely related particle size fastreacting drug means insulin injections precede mealtimes hours turn gives people diabetes flexibility daily insulin aggregate form fibrillar interdigitated betasheets cause injection amyloidosis prevents storage insulin long beta cells islets langerhans release insulin two phases firstphase release rapidly triggered response increased blood glucose levels lasts minutes second phase sustained slow release newly formed vesicles triggered independently sugar peaking hours two phases insulin release suggest insulin granules present diverse stated populations pools first phase insulin exocytosis granules predispose exocytosis released calcium internalization pool known readily releasable pool rrp rrp granules represent total insulincontaining granule population found immediately adjacent plasma membrane second phase exocytosis insulin granules require mobilization granules plasma membrane previous preparation undergo thus second phase insulin release governed rate granules get ready release pool known reserve pool rp rp released slower rrp rrp granulesmin rp reduced firstphase insulin release may earliest detectable beta cell defect predicting onset type firstphase release insulin sensitivity independent predictors description first phase release follows primary mechanism release insulin substances known stimulate insulin release include amino acids arginine leucine parasympathetic release acetylcholine acting via phospholipase c pathway sulfonylurea cholecystokinin cck also via phospholipase gastrointestinally derived incretins glucagonlike glucosedependent insulinotropic peptide gip release insulin strongly inhibited norepinephrine noradrenaline leads increased blood glucose levels stress appears release catecholamines sympathetic nervous system conflicting influences insulin release beta cells insulin release inhibited stimulated net effect norepinephrine sympathetic nerves epinephrine adrenal glands insulin release inhibition due dominance αadrenergic glucose level comes usual physiologic value insulin release βcells slows stops blood glucose level drops lower especially dangerously low levels release hyperglycemic hormones prominently glucagon islet langerhans alpha cells forces release glucose blood liver glycogen stores supplemented gluconeogenesis glycogen stores become depleted increasing blood glucose hyperglycemic hormones prevent correct lifethreatening hypoglycemia evidence impaired firstphase insulin release seen glucose tolerance test demonstrated substantially elevated blood glucose level minutes ingestion glucose load g glucose followed slow drop next minutes remain ml two hours start test normal person blood glucose level corrected may even slightly overcorrected end test insulin spike first response blood glucose increase response individual dose specific although always previously assumed food type specific even digestion general one two hours following meal insulin release pancreas continuous oscillates period minutes changing generating blood insulin concentration p moll less pmoll thought avoid downregulation insulin receptors target cells assist liver extracting insulin oscillation important consider administering insulinstimulating medication since oscillating blood concentration insulin release ideally achieved constant high may achieved delivering insulin rhythmically portal vein light activated delivery islet cell transplantation blood insulin level measured international units µiuml molar concentration pmoll µiuml equals typical blood level meals μiuml effects insulin initiated binding receptor insulin receptor ir present cell membrane receptor molecule contains α β subunits two molecules joined form known homodimer insulin binds αsubunits homodimer faces extracellular side cells β subunits tyrosine kinase enzyme activity triggered insulin binding activity provokes autophosphorylation β subunits subsequently phosphorylation proteins inside cell known insulin receptor substrates irs phosphorylation irs activates signal transduction cascade leads activation kinases well transcription factors mediate intracellular effects cascade leads insertion glucose transporters cell membranes muscle fat cells synthesis glycogen liver muscle tissue well conversion glucose triglycerides liver adipose lactating mammary gland tissue operates via activation phosphoinositol kinase enzyme converts phospholipid cell membrane name phosphatidylinositol phosphatidylinositol turn activates protein kinase b pkb activated pkb facilitates fusion containing endosomes cell membrane resulting increase transporters plasma pkb also phosphorylates glycogen synthase kinase gsk thereby inactivating means substrate glycogen synthase gs phosphorylated remains dephosphorylated therefore active active enzyme glycogen synthase gs catalyzes rate limiting step synthesis glycogen glucose similar dephosphorylations affect enzymes controlling rate glycolysis leading synthesis fats via malonylcoa tissues generate triglycerides also enzymes control rate gluconeogenesis liver overall effect final enzyme dephosphorylations tissues carry reactions glycogen fat synthesis glucose stimulated glucose production liver glycogenolysis gluconeogenesis breakdown triglycerides adipose tissue free fatty acids glycerol also intracellular signal resulted binding insulin receptor produced termination signaling needed mentioned section degradation endocytosis degradation receptor bound insulin main mechanism end addition signaling pathway also terminated dephosphorylation tyrosine residues various signaling pathways tyrosine phosphatases serinethreonine kinases also known reduce activity insulin structure receptor complex determined using techniques xray actions insulin global human metabolism level include actions insulin indirect direct cells include insulin also influences body functions vascular compliance cognition insulin enters human brain enhances learning memory benefits verbal memory enhancing brain insulin signaling means intranasal insulin administration also enhances acute thermoregulatory glucoregulatory response food intake suggesting central nervous insulin contributes coordination wide variety homeostatic regulatory processes human insulin also stimulatory effects gonadotropinreleasing hormone hypothalamus thus favoring insulin molecule docked onto receptor effected action may released back extracellular environment may degraded cell two primary sites insulin clearance liver broken enzyme proteindisulfide reductase breaks disulphide bonds b chains liver clears insulin firstpass transit whereas kidney clears insulin systemic circulation degradation normally involves endocytosis insulinreceptor complex followed action insulindegrading enzyme insulin molecule produced endogenously beta cells estimated degraded within one hour initial release circulation insulin halflife insulin major regulator endocannabinoid ec metabolism insulin treatment shown reduce intracellular ecs anandamide aea correspond insulinsensitive expression changes enzymes ec metabolism insulinresistant adipocytes patterns insulininduced enzyme expression disturbed manner consistent elevated ec synthesis reduced ec degradation findings suggest insulinresistant adipocytes fail regulate ec metabolism decrease intracellular ec levels response insulin stimulation whereby obese insulinresistant individuals exhibit increased concentrations dysregulation contributes excessive visceral fat accumulation reduced adiponectin release abdominal adipose tissue onset several cardiometabolic risk factors associated obesity type hypoglycemia also known low blood sugar blood sugar decreases normal may result variety symptoms including clumsiness trouble talking confusion loss consciousness seizures feeling hunger sweating shakiness weakness may also symptoms typically come common cause hypoglycemia medications used treat diabetes mellitus insulin risk greater diabetics eaten less usual exercised usual consumed causes hypoglycemia include kidney failure certain tumors insulinoma liver disease hypothyroidism starvation inborn error metabolism severe infections reactive hypoglycemia number drugs including low blood sugar may occur otherwise healthy babies eaten several conditions insulin disturbance pathologic biosynthetic human insulin insulin human rdna inn clinical use manufactured recombinant dna biosynthetic human insulin increased purity compared extractive animal insulin enhanced purity reducing antibody formation researchers succeeded introducing gene human insulin plants another method producing insulin biopharming technique anticipated reduce production costs several analogs human insulin available insulin analogs closely related human insulin structure developed specific aspects glycemic control terms fast action prandial insulins long action basal first biosynthetic insulin analog developed clinical use mealtime prandial insulin humalog insulin rapidly absorbed subcutaneous injection regular insulin effect minutes injection rapidacting analogues novorapid apidra similar rapidly absorbed due amino acid sequences reduce formation dimers hexamers monomeric insulins rapidly absorbed fast acting insulins require injectiontomeal interval previously recommended human insulin animal insulins type long acting insulin first lantus insulin glargine steady effect extended period hours likewise another protracted insulin analogue levemir based fatty acid acylation approach myristic acid molecule attached analogue associates insulin molecule abundant serum albumin turn extends effect reduces risk hypoglycemia protracted analogues need taken daily used type diabetics basal insulin combination rapid acting protracted insulin also available making likely patients achieve insulin profile mimics bodys insulin insulin also used many cell lines chos hek manufacturing monoclonal antibodies virus vaccines gene therapy insulin usually taken subcutaneous injections singleuse syringes needles via insulin pump repeateduse insulin pens disposable needles inhaled insulin also available us market dispovan singleuse pen needle india first insulin pen needle makes selfadministration easy featuring extrathin walls multibevel tapered point pen needles prioritise patient comfort minimising pain ensuring seamless medication delivery product aims provide affordable pen needles developing part country wide distribution channel additionally universal design needles guarantees compatibility insulin pens unlike many medicines insulin taken mouth like nearly proteins introduced gastrointestinal tract reduced fragments whereupon activity lost research ways protect insulin digestive tract administered orally world health organization added insulin model list essential insulin medications supplied free charge people diabetes national health service countries united studying structure pancreas microscope paul langerhans medical student berlin identified previously unnoticed tissue clumps scattered throughout bulk function little heaps cells later known islets langerhans initially remained unknown édouard laguesse later suggested might produce secretions play regulatory role paul langerhans son archibald also helped understand regulatory role physician oskar minkowski collaboration joseph von mering removed pancreas healthy dog test assumed role digestion testing urine found sugar establishing first time relationship pancreas diabetes another major step taken american physician scientist eugene lindsay opie isolated role pancreas islets langerhans diabetes mellitus result lesion pancreas caused destruction islands langerhans occurs bodies part wholly next two decades researchers made several attempts isolate islets secretions george ludwig zuelzer achieved partial success treating dogs pancreatic extract unable continue work el scott university chicago tried aqueous pancreatic extracts noted slight diminution glycosuria unable convince director works value shut israel kleiner demonstrated similar effects rockefeller university world war interrupted work return nicolae paulescu developed aqueous pancreatic extract injected diabetic dog normalizing effect blood sugar levels interrupt experiments world war wrote four papers work carried bucharest tests diabetic dog later year published research role pancreas food name insulin coined edward albert sharpeyschafer hypothetical molecule produced pancreatic islets langerhans latin insula islet island controls glucose metabolism unbeknown sharpeyschafer jean de meyer introduced similar word insuline october canadian frederick banting concluded digestive secretions minkowski originally studied breaking islet secretion thereby making impossible extract successfully surgeon training banting knew blockages pancreatic duct would lead pancreas atrophy leaving islets langerhans intact reasoned relatively pure extract could made islets rest pancreas gone jotted note ligate pancreatic ducts dog keep dogs alive till acini degenerate leaving islets try isolate internal secretion relieve spring banting traveled toronto explain idea john macleod professor physiology university toronto macleod initially skeptical since banting background research familiar latest literature agreed provide lab space banting test ideas macleod also arranged two undergraduates bantings lab assistants summer banting required one lab assistant charles best clark noble flipped coin best coin toss took first shift proved unfortunate noble banting kept best entire summer eventually shared half nobel prize money credit discovery july banting best successfully isolated extract isletin islets ducttied dog injected diabetic dog finding extract reduced blood sugar banting best presented results macleod return toronto fall macleod pointed flaws experimental design suggested experiments repeated dogs better equipment moved banting best better laboratory began paying banting salary research grants several weeks later second round experiments also success macleod helped publish results privately toronto november bottlenecked timeconsuming task ducttying dogs waiting several weeks extract insulin banting hit upon idea extracting insulin fetal calf pancreas yet developed digestive glands december also succeeded extracting insulin adult cow pancreas macleod discontinued research laboratory concentrate purification insulin invited biochemist james collip help task team felt ready clinical test within january leonard thompson diabetic lay dying toronto general hospital given first injection however extract impure thompson severe allergic reaction injections cancelled next days collip worked day night improve oxpancreas extract second dose injected january eliminating glycosuria typical diabetes without causing obvious sideeffects first american patient elizabeth hughes daughter us secretary state charles evans first patient treated us future woodcut artist james john ralston williams imported insulin toronto rochester new york treat banting best never worked well collip regarding something interlopercitation needed collip left project soon spring best managed improve techniques point large quantities insulin could extracted demand preparation remained impure drug firm eli lilly company offered assistance long first publications took lilly offer april november lillys head chemist george b walden discovered isoelectric precipitation able produce large quantities highly refined insulin shortly thereafter insulin offered sale general public toward end january tensions mounted four codiscoverers insulin collip briefly threatened separately patent purification process john g fitzgerald director noncommercial public health institution connaught laboratories therefore stepped peacemaker resulting agreement january established two key conditions collaborators would sign contract agreeing take patent commercial pharmaceutical firm initial working period connaught changes research policy would allowed unless first discussed among fitzgerald four helped contain disagreement tied research connaughts public mandate initially macleod banting particularly reluctant patent process insulin grounds medical ethics however concerns remained private thirdparty would hijack monopolize research eli lilly company safe distribution would difficult guarantee without capacity quality control end edward calvin kendall gave valuable advice isolated thyroxin mayo clinic patented process arrangement brothers mayo university minnesota transferring patent public april banting best collip macleod fitzgerald wrote jointly president university toronto propose similar arrangement aim assigning patent board governors letter emphasized patent would used purpose prevent taking patent persons details method preparation published anyone would free prepare extract one could secure profitable monopoly assignment university toronto board governors completed january token payment arrangement congratulated worlds work step forward medical also received much media attention regarding issue healthcare drug affordability following concern regarding eli lillys attempts separately patent parts manufacturing process connaughts assistant director head insulin division robert defries established patent pooling policy would require producers freely share improvements manufacturing process without compromising purified animalsourced insulin initially type insulin available experiments diabetics john jacob abel first produce crystallised form evidence protein nature first given michael somogyi edward doisy philip shaffer fully proven hans jensen earl evans jr isolated amino acids phenylalanine proline amino acid structure insulin first characterized frederick first synthetic insulin produced simultaneously labs panayotis katsoyannis university pittsburgh helmut zahn rwth aachen university synthetic crystalline bovine insulin achieved chinese researchers complete structure insulin determined xray crystallography dorothy hodgkins laboratory hans e weber discovered preproinsulin working research fellow university california los angeles weber learned techniques isolate purify translate messenger rna investigate insulin obtained pancreatic tissues slaughterhouse los angeles later animal stock ucla isolated purified total messenger rna pancreatic islet cells translated oocytes xenopus laevis precipitated using antiinsulin antibodies total translated protein run sdspolyacrylamide gel electrophoresis sucrose gradient peaks corresponding insulin proinsulin isolated however surprise weber third peak isolated corresponding molecule larger proinsulin reproducing experiment several times consistently noted large peak prior proinsulin determined must larger precursor molecule upstream proinsulin may american diabetes association meeting new york weber gave oral presentation first name precursor molecule preproinsulin following oral presentation weber invited dinner discuss paper findings donald steiner researcher contributed characterization proinsulin year later april molecule characterized sequenced steiner referencing work discovery hans preproinsulin became important molecule study process transcription translation first genetically engineered synthetic human insulin produced using e coli arthur riggs keiichi itakura beckman research institute city hope collaboration herbert boyer genentech founded swanson boyer eli lilly company went sell first commercially available biosynthetic human insulin brand name vast majority insulin used worldwide biosynthetic recombinant human insulin recently another approach used pioneering group canadian researchers using easily grown safflower plant production much cheaper recombinant insulin produced either yeast usually saccharomyces cerevisiae e yeast insulin may engineered singlechain protein kexii endoprotease yeast homolog pcipcii site separates insulin chain cterminally truncated insulin b chain chemically synthesized cterminal tail grafted onto insulin reverse proteolysis using inexpensive protease trypsin typically lysine cterminal tail protected chemical protecting group prevent proteolysis ease modular synthesis relative safety modifications region accounts common insulin analogs cterminal modifications eg lispro aspart glulisine genentech synthesis completely chemical synthesis bruce merrifield preferred efficiency recombining two insulin chains low primarily due competition precipitation insulin b chain nobel prize committee credited practical extraction insulin team university toronto awarded nobel prize two men frederick banting john awarded nobel prize physiology medicine discovery insulin banting incensed best shared prize macleod immediately shared james collip patent insulin sold university toronto one dollar two nobel prizes awarded work insulin british molecular biologist frederick sanger determined primary structure insulin awarded nobel prize rosalyn sussman yalow received nobel prize medicine development radioimmunoassay insulin several nobel prizes also indirect connection insulin george minot corecipient nobel prize development first effective treatment pernicious anemia diabetes mellitus william castle observed discovery insulin arriving time keep minot alive therefore also responsible discovery cure pernicious dorothy hodgkin awarded nobel prize chemistry development crystallography technique used deciphering complete molecular structure insulin work published banting best collip macleod represented preparation purified insulin extract suitable use human although paulescu discovered principles treatment saline extract could used humans mentioned nobel prize ian murray particularly active working correct historical wrong nicolae paulescu murray professor physiology anderson college medicine glasgow scotland head department metabolic diseases leading glasgow hospital vicepresident british association diabetes founding member international diabetes federation murray wrote insufficient recognition given paulescu distinguished romanian scientist time toronto team commencing research already succeeded extracting antidiabetic hormone pancreas proving efficacy reducing hyperglycaemia diabetic private communication arne tiselius former head nobel institute expressed personal opinion paulescu equally worthy award human insulin hexamer nonsymmetric nmr structures human insulin hexamer symmetric nmr structures conformational changes cubic insulin crystals ph range ph affects glu switching sulfate binding cubic insulin crystals ph coordinates ph affects glu switching sulfate binding cubic insulin crystals ph coordinates ph affects glu switching sulfate binding cubic insulin crystals ph coordinates ph affects glu switching sulfate binding cubic insulin crystals ph coordinates ph affects glu switching sulfate binding cubic insulin crystals ph coordinates ph affects glu switching sulfate binding cubic insulin crystals ph coordinates ph affects glu switching sulfate binding cubic insulin crystals ph coordinates ph affects glu switching sulfate binding cubic insulin crystals ph coordinates ph affects glu switching sulfate binding cubic insulin crystals ph coordinates ph affects glu switching sulfate binding cubic insulin crystals ph coordinates human insulin mutant insulin complexed conformational changes cubic insulin crystals ph range conformational changes cubic insulin crystals ph range conformational changes cubic insulin crystals ph range structure rhombohedral form mcresolinsulin hexamer structure monoclinic form mcresolinsulin hexamer structure resorcinolinsulin hexamer first protein structure determined xray powder diffraction data first protein structure determined xray powder diffraction data structure human insulin k structure human insulin k insulin ph structural analysis conditions promoting insulin fibre formation paradoxical structure function mutant human insulin associated diabetes mellitus receptor binding redefined structural switch mutant human insulin nmr structure human crystal structure destripeptide insulin role glu insulin assembly hexamer structure recombinant mutant glu gln insulin role glu insulin assembly hexamer structure recombinant mutant glu gln insulin crystal structure unstable insulin analog native activity nonstandard design unstable insulin analogues enhanced activity solution structure monomeric insulin mutant pt insulin insulin crystal structure resolution threedimensional solution structure insulin dimer study mutant human insulin using nuclear magnetic resonance distance geometry restrained molecular dynamics solution structure superactive monomeric human insulin mutant elucidation structural basis monomerization insulin dimerization native insulin xray crystallographic studies hexameric insulins presence helixstabilizing agents thiocyanate methylparaben phenol human insulin resolution dehydrated human insulin k dehydrated human insulin k crystal structure inactive chiral analogue implications mechanism receptor human insulin hexamers chain b mutated tyr complexed phenol human insulin hexamers chain b mutated tyr complexed resorcinol human insulin hexamers chain b mutated tyr enhancing activity insulin receptor edge crystal structure photocrosslinking analogues nmr structure human insulin amyloidogenic condition structures solution structure human proinsulin cpeptide crystallographic evidence dual coordination around zinc human insulin hexamer structure complex hexameric insulin structure complex hexameric insulin crystallographic solution studies nlithocholyl insulin new generation prolongedacting insulins structural properties insulin mutant crystal structure form b monoclinic crystal insulin structure insulin human insulin disulfide isomer nmr structures diabetesassociated mutations human insulin crystal structure photocrosslinking studies achain variant insulin wakayama structure asp insulin complex phenol structure insulin insulin insulin monoclinic crystal form structure bovine insulin human insulin hexamer symmetric nmr structures insulin high dose xray burn insulin high dose xray burn uv laser excited fluorescence uv laser excited fluorescence insulin collected wavelength crystal structure znbound human insulindegrading enzyme complex insulin b chain crystal structure human insulindegrading enzyme complex insulin b chain nmr structure human insulin acetic acid zincfree structures structure desphe bovine insulin structure human insulin cocrystallized protamine urea structure human insulin cocrystallized peptide presence urea structure human insulin cocrystallized protamine xray crystallographic studies hexameric insulins presence helixstabilizing agents thiocyanate methylparaben phenol human insulin hexamer symmetric nmr refined average structure structure insulin results joint neutron xray refinement xray crystallographic studies hexameric insulins presence helixstabilizing agents thiocyanate methylparaben phenol human insulin hexamer symmetric nmr green substate average structure structure pig insulin crystals angstroms resolution human insulin hexamer symmetric nmr red substate average structure xray analysis single chain peptidelinked insulin molecule completely inactive analogue structure porcine insulin cocrystallized clupeine z monovalent cation binding cubic insulin crystals httpsenwikipediaorgwikiinsulin